MSB 4.89% $1.07 mesoblast limited

Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-428

  1. 6,783 Posts.
    lightbulb Created with Sketch. 1469
    and nippy, I’ve been wanting to put this quote up for awhile ....

    ’Current’ group in FDA... going against the ODAC 9-1 vote in favour of REMESTEMCEL-L for treatment for SR-agvhd....

    https://hotcopper.com.au/data/attachments/2709/2709862-2538b855423ea83381b2c463f048e93c.jpg


    Last edited by Wilba32: 06/12/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.